Deutsch
English

© 2013 Leibniz-Institut für Virologie

SARS-CoV-2 variants

Current data by the Hamburg Surveillance Platform

Last Update: 19.09.2022

Link to the website

HPI becomes LIV - Leibniz Institute of Virology

Relaunch with new name and logo on May 9, 2022

To the press release

The LIV

The institute's mission statement: „The LIV investigates the biology of human pathogenic viruses. It is our aim to unravel the molecular mechanisms that control viral life cycles and virus induced pathogenesis. This research will provide novel targets and therapeutic approaches for established and emerging viral diseases.“ Learn more about the LIV.

Coronavirus

SARS-CoV-2/COVID-19:

Current Information, Links & Adresses

Exterior view of the HPI building

News

August 5, 2022: Human Cytomegalovirus - New Exit Pathway Revealed

Friday, 05. August 2022

August 5, 2022: Results published in PLOS Pathogens

July 4, 2022: LIV Summer Party

Monday, 04. July 2022

July 4, 2022: Ceremony for the PhD and Postdoctoral Award and the Mobility Grant

Press

SARS-CoV-2: Antiviral treatment promotes emergence of new variants

Wednesday, 17. August 2022

Study published in Cell Reports Medicine

Institute renaming: HPI becomes LIV - Leibniz Institute of Virology

Monday, 09. May 2022

Relaunch with new name and logo

Seminars

Digital Institute Seminar (intern)

Every Tuesday from 9.30am.

More information HERE.